GlaxoSmithKline PLC banner

Intrinsic Value

The intrinsic value of GlaxoSmithKline PLC (GLAXF) under the Base Case is 23.19 USD per share. Compared with the current market price of 23.4 USD, the stock appears Overvalued by 1% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

GLAXF Intrinsic Value
$23.19
Overvaluation 1%
Intrinsic Value
Price $23.4

GLAXF is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alert me when GLAXF is below its intrinsic value
Today $18.55 · 20.7% below the current price
Alternatives to GLAXF

Fundamental Analysis

What GlaxoSmithKline Does

Pharmaceuticals Health Care

GlaxoSmithKline, or GSK, is a global drug maker focused on prescription medicines and vaccines. It develops and sells treatments for areas such as respiratory disease, HIV, immunology, oncology, and infectious disease, along with vaccines for children, adults, and travel-related prevention. Its main customers are governments, health systems, hospitals, doctors, and pharmacies that buy and distribute its products to patients.

Headquarters
United Kingdom UK
Employees
90 096
IPO date
May 22, 1972
Read the full company overview
View Company Overview

GlaxoSmithKline has no economic moat

No Moat Narrow Wide

Protection rests on individual medicines rather than a lasting barrier around GSK as a whole: patents protect particular drugs, while competing treatments can still reach customers. Generic competition in established medicines shows why successful products do not guarantee lasting protection across the business.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · October 28, 2026

GSK reconfirmed its 2026 outlook as specialty-led momentum continued, while management highlighted pipeline expansion and ongoing launch, vaccine-market and HIV-development uncertainties.

Open the earnings call
EPS
GBX 0.55
Expected
GBX 0.53
Surprise
+3.0%
Stock, next trading day
−1.0%
View Earnings Call

Past 12 months

Continue GLAXF Research

Decided on GlaxoSmithKline? Get an email when GLAXF reaches the price you’d buy at. Free with an account.

Other GlaxoSmithKline listings

What is the Intrinsic Value of one GLAXF stock?

The intrinsic value for GlaxoSmithKline PLC (GLAXF) under the Base Case is 23.19 USD.

Is GLAXF stock undervalued or overvalued?

Compared with the current market price of 23.4 USD, the stock appears Overvalued by 1% .

How reliable are our estimates? See how past valuations played out
Back to Top